| Year |
Citation |
Score |
| 2017 |
Buttermore ST, Hoffman MS, Kumar A, Champeaux A, Nicosia SV, Kruk PA. Increased RHAMM expression relates to ovarian cancer progression. Journal of Ovarian Research. 10: 66. PMID 28954627 DOI: 10.1186/S13048-017-0360-1 |
0.475 |
|
| 2016 |
Mohamed M, Kruk P. Abstract 5080: Amylase overexpression promotes ovarian cancer invasion Cancer Research. 76: 5080-5080. DOI: 10.1158/1538-7445.Am2016-5080 |
0.533 |
|
| 2016 |
Buttermore S, Kruk P. Abstract 444: Hyaluronan-mediated motility receptor (RHAMM) in ovarian cancer Cancer Research. 76: 444-444. DOI: 10.1158/1538-7445.Am2016-444 |
0.48 |
|
| 2015 |
Woolery KT, Mohamed M, Linger RJ, Dobrinski KP, Roman J, Kruk PA. BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells. Biomed Research International. 2015: 652017. PMID 26357657 DOI: 10.1155/2015/652017 |
0.774 |
|
| 2015 |
Dobrinski KP, Drenberg CD, Edelman JL, Buttermore ST, Mohamed M, Uversky VN, Hoffman MS, Nicosia SV, Kruk PA. Increased High Mobility Group Protein A2/SMAD3 Relates to Ovarian Cancer Progression Journal of Gynecology Research. 1. DOI: 10.15744/2454-3284.1.104 |
0.735 |
|
| 2014 |
Dobrinski K, Esposito NN, Kruk PA, Wenham R, Hoffman M, Coppola D, Bai W, Zhang X, Siddique N, Nicosia SV. Procurement and cytological features of human fallopian tube fimbrial cells by ex vivo imprinting and washing. Journal of the American Society of Cytopathology. 3: 309-318. PMID 31051721 DOI: 10.1016/J.Jasc.2014.07.002 |
0.386 |
|
| 2014 |
Woolery KT, Hoffman MS, Kraft J, Nicosia SV, Kumar A, Kruk PA. Urinary interleukin-1β levels among gynecological patients. Journal of Ovarian Research. 7: 104. PMID 25403235 DOI: 10.1186/S13048-014-0104-4 |
0.307 |
|
| 2012 |
Kasiappan R, Shen Z, Tse AK, Jinwal U, Tang J, Lungchukiet P, Sun Y, Kruk P, Nicosia SV, Zhang X, Bai W. 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. The Journal of Biological Chemistry. 287: 41297-309. PMID 23055531 DOI: 10.1074/Jbc.M112.407189 |
0.43 |
|
| 2012 |
Onen O, Sisman A, Gallant ND, Kruk P, Guldiken R. A urinary Bcl-2 surface acoustic wave biosensor for early ovarian cancer detection. Sensors (Basel, Switzerland). 12: 7423-37. PMID 22969352 DOI: 10.3390/S120607423 |
0.351 |
|
| 2012 |
Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. The Journal of Biological Chemistry. 287: 34970-8. PMID 22927443 DOI: 10.1074/Jbc.M112.374611 |
0.325 |
|
| 2012 |
Henderson E, Kruk P, Bui M, Nicosia S. Expression of High Motility Group A2 Protein in Malignant Ascites from Epithelial Ovarian Cancer Journal of the American Society of Cytopathology. 1: S53-S54. DOI: 10.1016/J.Jasc.2012.08.119 |
0.415 |
|
| 2011 |
Woolery KT, Kruk PA. Ovarian epithelial-stromal interactions: role of interleukins 1 and 6. Obstetrics and Gynecology International. 2011: 358493. PMID 21765834 DOI: 10.1155/2011/358493 |
0.406 |
|
| 2011 |
Woolery KT, Linger RJ, Kruk PA. Abstract 2030: A novel role for the 185delAG BRCA1 mutant protein, BRAT, in ovarian cancer pathology Cellular and Molecular Biology. 71: 2030-2030. DOI: 10.1158/1538-7445.Am2011-2030 |
0.802 |
|
| 2010 |
Linger RJ, Kruk PA. BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications. The Febs Journal. 277: 3086-96. PMID 20608970 DOI: 10.1111/J.1742-4658.2010.07735.X |
0.791 |
|
| 2010 |
Drenberg CD, Saunders BO, Wilbanks GD, Chen R, Nicosia RF, Kruk PA, Nicosia SV. Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer. Gynecologic Oncology. 117: 117-24. PMID 20071014 DOI: 10.1016/J.Ygyno.2009.12.011 |
0.755 |
|
| 2010 |
O'Donnell JD, Linger RJ, Kruk PA. BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells. Gynecologic Oncology. 116: 262-8. PMID 19906413 DOI: 10.1016/J.Ygyno.2009.10.052 |
0.755 |
|
| 2010 |
Drenberg CD, Bermudez Y, Nicosia SV, Kruk PA. Abstract 3208: Semaphorin 3F suppresses telomerase activity Cancer Research. 70: 3208-3208. DOI: 10.1158/1538-7445.Am10-3208 |
0.809 |
|
| 2010 |
Linger RJ, Kruk PA. Abstract 1852: A novel role for the 185delAG BRCA1 mutant protein, BRAT, in ovarian cancer pathology Cancer Research. 70: 1852-1852. DOI: 10.1158/1538-7445.Am10-1852 |
0.804 |
|
| 2010 |
Anderson NS, Rojiani M, Kruk PA. Abstract 1037: Lysophosphatidic acid upregulates Bcl-2 production and secretion in ovarian cancer cells Cancer Research. 70: 1037-1037. DOI: 10.1158/1538-7445.Am10-1037 |
0.526 |
|
| 2009 |
Drenberg CD, Livingston S, Chen R, Kruk PA, Nicosia SV. Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues. Obstetrics and Gynecology International. 2009: 730739. PMID 20041133 DOI: 10.1155/2009/730739 |
0.725 |
|
| 2009 |
Anderson NS, Turner L, Livingston S, Chen R, Nicosia SV, Kruk PA. Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation. Journal of Ovarian Research. 2: 16. PMID 19852858 DOI: 10.1186/1757-2215-2-16 |
0.43 |
|
| 2009 |
Guo JP, Shu SK, He L, Lee YC, Kruk PA, Grenman S, Nicosia SV, Mor G, Schell MJ, Coppola D, Cheng JQ. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. The American Journal of Pathology. 175: 324-33. PMID 19497997 DOI: 10.2353/Ajpath.2009.080767 |
0.461 |
|
| 2009 |
Anderson NS, Bermudez Y, Badgwell D, Chen R, Nicosia SV, Bast RC, Kruk PA. Urinary levels of Bcl-2 are elevated in ovarian cancer patients. Gynecologic Oncology. 112: 60-7. PMID 19007973 DOI: 10.1016/J.Ygyno.2008.09.037 |
0.779 |
|
| 2009 |
Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, Kruk PA, Cheng JQ, Bai W, Chen J, Nicosia SV, Zhang X. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene. 28: 445-60. PMID 18850005 DOI: 10.1038/Onc.2008.388 |
0.43 |
|
| 2008 |
O'Donnell JD, Johnson NC, Turbeville TD, Alfonso MY, Kruk PA. BRCA1 185delAG truncation protein, BRAt, amplifies caspase-mediated apoptosis in ovarian cells. In Vitro Cellular & Developmental Biology. Animal. 44: 357-67. PMID 18594935 DOI: 10.1007/S11626-008-9122-0 |
0.81 |
|
| 2008 |
Bermudez Y, Yang H, Cheng JQ, Kruk PA. Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor. Growth Factors (Chur, Switzerland). 26: 1-11. PMID 18365874 DOI: 10.1080/08977190802001389 |
0.805 |
|
| 2008 |
Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research. 68: 425-33. PMID 18199536 DOI: 10.1158/0008-5472.Can-07-2488 |
0.76 |
|
| 2008 |
Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN (Cancer Research (2008) 68, (425-433)) Cancer Research. 68: 1609. DOI: 10.1158/0008-5472.Can-68-5-Cor4 |
0.793 |
|
| 2007 |
Bermudez Y, Yang H, Saunders BO, Cheng JQ, Nicosia SV, Kruk PA. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecologic Oncology. 106: 526-37. PMID 17559911 DOI: 10.1016/J.Ygyno.2007.05.005 |
0.791 |
|
| 2007 |
Bermudez Y, Ahmadi S, Lowell NE, Kruk PA. Vitamin E suppresses telomerase activity in ovarian cancer cells. Cancer Detection and Prevention. 31: 119-28. PMID 17335992 DOI: 10.1016/J.Cdp.2006.12.002 |
0.777 |
|
| 2006 |
Bermudez Y, Erasso D, Johnson NC, Alfonso MY, Lowell NE, Kruk PA. Telomerase confers resistance to caspase-mediated apoptosis. Clinical Interventions in Aging. 1: 155-67. PMID 18044112 DOI: 10.2147/Ciia.2006.1.2.155 |
0.757 |
|
| 2006 |
Yang H, He L, Kruk P, Nicosia SV, Cheng JQ. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. International Journal of Cancer. Journal International Du Cancer. 119: 2304-12. PMID 16894566 DOI: 10.1002/Ijc.22154 |
0.489 |
|
| 2005 |
Tebes SJ, Johnson NC, Fiorica JV, Kruk PA. Inhibition of telomerase in ovarian cancer using siRNA technology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3182. PMID 27945989 DOI: 10.1200/Jco.2005.23.16_Suppl.3182 |
0.492 |
|
| 2005 |
Elahi A, Martino MA, Cragun J, Goldberg MI, Hoffman MS, Tebes S, Klippel C, Kruk P, Sutphen R, Lancaster J. Silencing pathways that underlie platinum resistance in ovarian cancer cells using small interfering RNA Journal of Clinical Oncology. 23: 5117-5117. DOI: 10.1200/Jco.2005.23.16_Suppl.5117 |
0.4 |
|
| 2004 |
Johnson NC, Dan HC, Cheng JQ, Kruk PA. BRCA1 185delAG mutation inhibits Akt-dependent, IAP-mediated caspase 3 inactivation in human ovarian surface epithelial cells. Experimental Cell Research. 298: 9-16. PMID 15242757 DOI: 10.1016/J.Yexcr.2004.04.003 |
0.432 |
|
| 2004 |
Nicosia SV, Wilbanks GD, Saunders B, Mayer J, Cardosi RJ, Kruk PA, Cheng J, Bai W, Coppola D, Fiorica J. Cytology of human ovarian surface epithelial brushings. Cancer. 102: 1-10. PMID 14968412 DOI: 10.1002/Cncr.20001 |
0.391 |
|
| 2004 |
Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, Cheng JQ. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Research. 64: 463-7. PMID 14744757 DOI: 10.1158/0008-5472.Can-03-2907 |
0.476 |
|
| 2004 |
Alfonso-De Matte MY, Kruk PA. Phosphatidylinositol triphosphate kinase-dependent and c-jun NH2-terminal kinase-dependent induction of telomerase by calcium requires Pyk2. Cancer Research. 64: 23-6. PMID 14729602 DOI: 10.1158/0008-5472.Can-03-2820 |
0.752 |
|
| 2003 |
Nicosia SV, Bai W, Cheng JQ, Coppola D, Kruk PA. Oncogenic pathways implicated in ovarian epithelial cancer. Hematology/Oncology Clinics of North America. 17: 927-43. PMID 12959183 DOI: 10.1016/S0889-8588(03)00056-X |
0.48 |
|
| 2002 |
Johnson NC, Kruk PA. BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells. Cancer Cell International. 2: 7. PMID 12234376 DOI: 10.1186/1475-2867-2-7 |
0.424 |
|
| 2002 |
Alfonso-De Matte MY, Yang H, Evans MS, Cheng JQ, Kruk PA. Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells. Cancer Research. 62: 4575-8. PMID 12183409 |
0.776 |
|
| 2002 |
Alfonso-De Matte MY, Moses-Soto H, Kruk PA. Calcium-mediated telomerase activity in ovarian epithelial cells. Archives of Biochemistry and Biophysics. 399: 239-44. PMID 11888211 DOI: 10.1006/Abbi.2002.2762 |
0.77 |
|
| 2001 |
Alfonso-De Matte MY, Cheng JQ, Kruk PA. Ultraviolet irradiation- and dimethyl sulfoxide-induced telomerase activity in ovarian epithelial cell lines. Experimental Cell Research. 267: 13-27. PMID 11412034 DOI: 10.1006/Excr.2001.5231 |
0.782 |
|
| 1999 |
Kruk PA, Godwin AK, Hamilton TC, Auersperg N. Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer Gynecologic Oncology. 73: 229-236. PMID 10329039 DOI: 10.1006/Gyno.1999.5348 |
0.457 |
|
| 1999 |
Kruk PA, Bohr VA. Telomeric length in individuals and cell lines with altered p53 status Radiation Oncology Investigations. 7: 13-21. PMID 10030619 DOI: 10.1002/(Sici)1520-6823(1999)7:1<13::Aid-Roi2>3.0.Co;2-7 |
0.425 |
|
| 1997 |
Kruk PA, Orren DK, Bohr VA. Telomerase activity is elevated in early S phase in hamster cells Biochemical and Biophysical Research Communications. 233: 717-722. PMID 9168921 DOI: 10.1006/Bbrc.1997.6549 |
0.362 |
|
| 1996 |
Kruk PA, Balajee AS, Rao KS, Bohr VA. Telomere reduction and telomerase inactivation during neuronal cell differentiation Biochemical and Biophysical Research Communications. 224: 487-492. PMID 8702416 DOI: 10.1006/Bbrc.1996.1054 |
0.329 |
|
| 1994 |
Kruk PA, Uitto VJ, Firth JD, Dedhar S, Auersperg N. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix Experimental Cell Research. 215: 97-108. PMID 7525326 DOI: 10.1006/Excr.1994.1320 |
0.373 |
|
| 1992 |
Kruk PA, Auersperg N. Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix American Journal of Obstetrics and Gynecology. 167: 1437-1443. PMID 1443002 DOI: 10.1016/S0002-9378(11)91730-X |
0.35 |
|
| 1992 |
Maines-Bandiera SL, Kruk PA, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix American Journal of Obstetrics and Gynecology. 167: 729-735. PMID 1326894 DOI: 10.1016/S0002-9378(11)91579-8 |
0.359 |
|
| 1991 |
Auersperg N, Maclaren IA, Kruk PA. Ovarian surface epithelium: Autonomous production of connective tissue-type extracellular matrix Biology of Reproduction. 44: 717-724. PMID 1710511 DOI: 10.1095/Biolreprod44.4.717 |
0.365 |
|
| Show low-probability matches. |